31 December 2025 in Journal of Healthcare and Biomedical Science
Background: Cancer remains one of the most significant global health challenges and radiotherapy continues to be one of the most effective treatment options. However, Patients are also exposed to low doses of ionizing radiation during diagnostic procedures such as computed tomography (CT) and magnetic resonance imaging (MRI). These exposures can induce various cellular and molecular defects in the human body. Therefore, there is an urgent need to develop safer and more reliable radioprotective agents to minimize radiation induced damage. Method: This review was prepared using selected keywords searched across major scientific databases including ScienceDirect, PubMed, Web of Science, MEDLINE, Embase, Scopus, Google Scholar and SCISEARCH covering publications from the inception of each data base up to October 14, 2025. Key findings: This review discusses various plants with reported radioprotective properties and compares the significance of naturally derived and pharmaceutical radioprotective agents. Conclusion: Radioprotective agents offer several advantages in both oncotherapy and diagnostic applications. However, many synthetic radioprotectors are associated with limitations such as high cost, short duration of action, toxicity and adverse effects on the central nervous system. In contrast natural radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced radioprotectors derived from plants have shown the potential to safeguard normal cells from radiation induced damage more effectively and safely than their synthetic counterparts. The aim of this review is to identify safer and more effective radioprotective agents for use by oncologists and radiation biologists.